Skip to main content
Top
Published in: BMC Health Services Research 1/2018

Open Access 01-12-2018 | Research article

Service provision of non-invasive prenatal testing for Down syndrome in public and private healthcare sectors: a qualitative study with obstetric providers

Authors: Olivia Miu Yung Ngan, Huso Yi, Shenaz Ahmed

Published in: BMC Health Services Research | Issue 1/2018

Login to get access

Abstract

Background

Cell-free fetal DNA sequencing based non-invasive prenatal testing (NIPT) for Down syndrome (DS) has become widely available. In Hong Kong, obstetric providers in the public sector refer women identified at high risk of having a child with Down syndrome to obstetric providers in the private sector for NIPT. Little is known about how the NIPT has been adopted in the public sector where DS screening is provided for free of charge. The study aimed to identify the factors influencing providers’ role enactment, such as consultation and referral, in the service provision of NIPT for DS in public and private healthcare sectors.

Methods

In-depth interviews were conducted with 20 obstetric providers offering NIPT in Hong Kong. Thematic narrative analysis was used to identify (i) the factors considered by participants when referring women for NIPT for Down syndrome in public and private healthcare sectors and (ii) their perceptions of the need to integrate NIPT into the current public antenatal service.

Results

Participants raised concerns about the lack of transparent referral guideline between public and private sectors for NIPT. Public obstetric providers reported little obligation to provide women with much information about risks and benefits of NIPT as it was not provided by public sectors. Some private providers assumed that women referred from the public sector had already received sufficient information about NIPT. The providers were also concerned about potential application of NIPT for further detection without regulation.

Conclusions

Although the providers had good knowledge of clinical advantages of NIPT over conventional screening, they were uncertain about how to introduce NIPT to women. Guidelines are necessary to enable better coordination of public and private sectors services to enable women to make informed choices about the uptake of NIPT.
Literature
1.
go back to reference Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CWG, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485–7.CrossRef Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CWG, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485–7.CrossRef
2.
go back to reference Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50:302–14.CrossRef Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50:302–14.CrossRef
3.
go back to reference Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotripin and pregnancy-associated plasma protein-a. Ultrasound Obstet Gynecol. 2008;31:618–24.CrossRef Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotripin and pregnancy-associated plasma protein-a. Ultrasound Obstet Gynecol. 2008;31:618–24.CrossRef
4.
go back to reference Allyse M, Minear M, Berson E, Sridhar S, Rote M, Hung A, et al. Non-invasive prenatal testing: a review of international implementation and challenges. Int J Womens Health. 2015;7:113–26.CrossRef Allyse M, Minear M, Berson E, Sridhar S, Rote M, Hung A, et al. Non-invasive prenatal testing: a review of international implementation and challenges. Int J Womens Health. 2015;7:113–26.CrossRef
5.
go back to reference Benn P, Borrell A, Chiu RWK, Cuckle H, Dugoff L, Faas B, et al. Position statement from the chromosome abnormality screening committee on behalf of the board of the International Society for Prenatal Diagnosis. Prenat Diagn. 2015;35:725–34.CrossRef Benn P, Borrell A, Chiu RWK, Cuckle H, Dugoff L, Faas B, et al. Position statement from the chromosome abnormality screening committee on behalf of the board of the International Society for Prenatal Diagnosis. Prenat Diagn. 2015;35:725–34.CrossRef
6.
go back to reference Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther. 2010;27:1–7.CrossRef Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther. 2010;27:1–7.CrossRef
7.
go back to reference Yi H, Hallowell N, Griffiths S, Leung TY. Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: a qualitative study with early adopter patients in Hong Kong. PLoS One. 2013;8:e81794.CrossRef Yi H, Hallowell N, Griffiths S, Leung TY. Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: a qualitative study with early adopter patients in Hong Kong. PLoS One. 2013;8:e81794.CrossRef
8.
go back to reference Hodgson JM, Gillam LH, Sahhar MA, Metcalfe SA. ‘Testing times, challenging choices’: an Australian study of prenatal genetic counseling. J Genet Couns. 2010;19:22–37.CrossRef Hodgson JM, Gillam LH, Sahhar MA, Metcalfe SA. ‘Testing times, challenging choices’: an Australian study of prenatal genetic counseling. J Genet Couns. 2010;19:22–37.CrossRef
9.
go back to reference Donchin A. Understanding autonomy relationally: toward a reconfiguration of bioethical principles. J Med Philos. 2001;26:365–86.CrossRef Donchin A. Understanding autonomy relationally: toward a reconfiguration of bioethical principles. J Med Philos. 2001;26:365–86.CrossRef
10.
go back to reference van den Heuvel A, Chitty L, Dormandy E, Newson A, Deans Z, Attwood S, et al. Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals. Patient Educ Couns. 2010;78:24–8.CrossRef van den Heuvel A, Chitty L, Dormandy E, Newson A, Deans Z, Attwood S, et al. Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals. Patient Educ Couns. 2010;78:24–8.CrossRef
11.
go back to reference Musci TJ, Fairbrother G, Batey A, Bruursema J, Struble C, Song K. Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice. Prenat Diagn. 2013;33:424–8.CrossRef Musci TJ, Fairbrother G, Batey A, Bruursema J, Struble C, Song K. Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice. Prenat Diagn. 2013;33:424–8.CrossRef
12.
go back to reference Kou KO, Poon CF, Tse WC, Mak SL, Leung KY. Knowledge and future preference of Chinese women in a major public hospital in Hong Kong after undergoing non-invasive prenatal testing for positive aneuploidy screening: a questionnaire survey. BMC Pregnancy Childbirth. 2015;15:199.CrossRef Kou KO, Poon CF, Tse WC, Mak SL, Leung KY. Knowledge and future preference of Chinese women in a major public hospital in Hong Kong after undergoing non-invasive prenatal testing for positive aneuploidy screening: a questionnaire survey. BMC Pregnancy Childbirth. 2015;15:199.CrossRef
13.
go back to reference Lau JYC, Yi H, Ahmed S. Decision-making for non-invasive prenatal testing for Down syndrome: Hong Kong Chinese women’s preferences for individual vs relational autonomy. Clin Genet. 2016;89:550–6.CrossRef Lau JYC, Yi H, Ahmed S. Decision-making for non-invasive prenatal testing for Down syndrome: Hong Kong Chinese women’s preferences for individual vs relational autonomy. Clin Genet. 2016;89:550–6.CrossRef
14.
go back to reference Skirton H, Goldsmith L, Jackson L, Lewis C, Chitty LS. Non-invasive prenatal testing for aneuploidy: a systematic review of internet advertising to potential users by commercial companies and private health providers. Prent Diagn. 2015;35:1167–75.CrossRef Skirton H, Goldsmith L, Jackson L, Lewis C, Chitty LS. Non-invasive prenatal testing for aneuploidy: a systematic review of internet advertising to potential users by commercial companies and private health providers. Prent Diagn. 2015;35:1167–75.CrossRef
15.
go back to reference Martin L, Gitsels-van der Wal JT, de Boer MA, Vanstone M, Henneman L. Introduction of non-invasive prenatal testing as a first-tier aneuploidy screening test: a survey among Dutch midwives about their role as counsellors. Midwifery. 2018;56:1–8.CrossRef Martin L, Gitsels-van der Wal JT, de Boer MA, Vanstone M, Henneman L. Introduction of non-invasive prenatal testing as a first-tier aneuploidy screening test: a survey among Dutch midwives about their role as counsellors. Midwifery. 2018;56:1–8.CrossRef
16.
go back to reference Swaney P, Hardisty E, Sayres L, Wiegand S, Vora N. Attitudes and knowledge of maternal-fetal medicine fellows regarding noninvasive prenatal testing. J Genet Couns. 2015;25:73–8.CrossRef Swaney P, Hardisty E, Sayres L, Wiegand S, Vora N. Attitudes and knowledge of maternal-fetal medicine fellows regarding noninvasive prenatal testing. J Genet Couns. 2015;25:73–8.CrossRef
17.
go back to reference Yi H, Ngan OMY, Griffiths S, Sahota D. Ethical concerns in the implementation of DNA sequencing-based noninvasive prenatal testing for fetal aneuploidy among obstetric professionals in Hong Kong. AJOB Empir Bioeth. 2015;6:81–93.CrossRef Yi H, Ngan OMY, Griffiths S, Sahota D. Ethical concerns in the implementation of DNA sequencing-based noninvasive prenatal testing for fetal aneuploidy among obstetric professionals in Hong Kong. AJOB Empir Bioeth. 2015;6:81–93.CrossRef
18.
go back to reference Ngan OMY, Yi H, Wong SYS, Sahota D, Ahmed S. Obstetric professionals’ perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications. BMC Pregnancy Childbirth. 2017;17:285.CrossRef Ngan OMY, Yi H, Wong SYS, Sahota D, Ahmed S. Obstetric professionals’ perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications. BMC Pregnancy Childbirth. 2017;17:285.CrossRef
19.
go back to reference Lewis C, Hill M, Chitty LS. Women's experiences and preferences for service delivery of non-invasive prenatal testing for aneuploidy in a public health setting: a mixed methods study. PLoS One. 2016;11:e0153147.CrossRef Lewis C, Hill M, Chitty LS. Women's experiences and preferences for service delivery of non-invasive prenatal testing for aneuploidy in a public health setting: a mixed methods study. PLoS One. 2016;11:e0153147.CrossRef
20.
go back to reference Dane AC, Peterson M, Miller YD. Talking points: women’s information needs for informed decision-making about noninvasive prenatal testing for Down syndrome. J Genet Couns. 2018;17:1258–64.CrossRef Dane AC, Peterson M, Miller YD. Talking points: women’s information needs for informed decision-making about noninvasive prenatal testing for Down syndrome. J Genet Couns. 2018;17:1258–64.CrossRef
21.
go back to reference Vanstone M, Yacoub K, Giacomini M, Hulan D, McDonald S. Women’s experiences of publicly funded non-invasive prenatal testing in Ontario, Canada: considerations for health technology policy-making. Qual Health Res. 2015;25:1069–84.CrossRef Vanstone M, Yacoub K, Giacomini M, Hulan D, McDonald S. Women’s experiences of publicly funded non-invasive prenatal testing in Ontario, Canada: considerations for health technology policy-making. Qual Health Res. 2015;25:1069–84.CrossRef
23.
go back to reference Choi SSN, Chan LW, To WKW. Pregnant women’s attitudes to and knowledge of non-invasive prenatal testing in Down syndrome screening in Hong Kong. Hong Kong J Gynaecol Obstet Midwifery. 2014;14:43–50. Choi SSN, Chan LW, To WKW. Pregnant women’s attitudes to and knowledge of non-invasive prenatal testing in Down syndrome screening in Hong Kong. Hong Kong J Gynaecol Obstet Midwifery. 2014;14:43–50.
24.
go back to reference Feeney MK, Bozeman B. Stakeholder red tape: comparing perceptions of public managers and their private consultants. Publ Admin Rev. 2009;69:710–26.CrossRef Feeney MK, Bozeman B. Stakeholder red tape: comparing perceptions of public managers and their private consultants. Publ Admin Rev. 2009;69:710–26.CrossRef
25.
go back to reference de Graaf G, van der Wal Z. On value differences experienced by sector switchers. Adm Soc. 2008;40:79–103.CrossRef de Graaf G, van der Wal Z. On value differences experienced by sector switchers. Adm Soc. 2008;40:79–103.CrossRef
26.
go back to reference Nutt PC. Comparing public and private sector decision-making practices. J Public Adm Res Theory. 2006;16:289–318.CrossRef Nutt PC. Comparing public and private sector decision-making practices. J Public Adm Res Theory. 2006;16:289–318.CrossRef
27.
go back to reference Fetters MD, Curry LA, Creswell JW. Achieving integration in mixed methods designs— principles and practices. Health Serv Res. 2013;48:2134–56.CrossRef Fetters MD, Curry LA, Creswell JW. Achieving integration in mixed methods designs— principles and practices. Health Serv Res. 2013;48:2134–56.CrossRef
28.
go back to reference Patton MQ. Qualitative evaluation and research methods. 3rd ed. Thousand Oaks, CA: Sage; 2002. Patton MQ. Qualitative evaluation and research methods. 3rd ed. Thousand Oaks, CA: Sage; 2002.
29.
go back to reference Glaser BG, Strauss AL. The discovery of grounded theory: strategies for qualitative research. Chicago: Aldine Publishing; 1967. Glaser BG, Strauss AL. The discovery of grounded theory: strategies for qualitative research. Chicago: Aldine Publishing; 1967.
30.
go back to reference Sandelowski M. Sample size in qualitative research. Res Nurs Health. 1995;18:179–83.CrossRef Sandelowski M. Sample size in qualitative research. Res Nurs Health. 1995;18:179–83.CrossRef
31.
go back to reference Patton MQ. Qualitative research & evaluation methods. 3rd ed. Thousand Oaks, CA: SAGE Publications; 2002. Patton MQ. Qualitative research & evaluation methods. 3rd ed. Thousand Oaks, CA: SAGE Publications; 2002.
32.
go back to reference Ahmed S, Bryant LD, Tizro Z, Shickle D. Is advice incompatible with autonomous informed choice? women’s perceptions of advice in the context of antenatal screening: a qualitative study. Health Expect. 2014;17:555–64.CrossRef Ahmed S, Bryant LD, Tizro Z, Shickle D. Is advice incompatible with autonomous informed choice? women’s perceptions of advice in the context of antenatal screening: a qualitative study. Health Expect. 2014;17:555–64.CrossRef
33.
go back to reference De Jong A, De Wert GMWR. Prenatal screening: an ethical agenda for the near future. Bioethics. 2015;29:46–55.CrossRef De Jong A, De Wert GMWR. Prenatal screening: an ethical agenda for the near future. Bioethics. 2015;29:46–55.CrossRef
34.
go back to reference Leach MW. Unjustified: the imbalance of information and funding with noninvasive prenatal screening. AJOB Empirical Bioethics. 2015;6:21–30.CrossRef Leach MW. Unjustified: the imbalance of information and funding with noninvasive prenatal screening. AJOB Empirical Bioethics. 2015;6:21–30.CrossRef
35.
go back to reference American College of Obstetricians and Gynecologists Committee on Practice Bulletins. ACOG practice bulletin no. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol. 2007;109:217–27.CrossRef American College of Obstetricians and Gynecologists Committee on Practice Bulletins. ACOG practice bulletin no. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol. 2007;109:217–27.CrossRef
36.
go back to reference Colicchia LC, Holland CL, Tarr JA, Rubio DM, Rothenberger SD, Chang JC. Patient–health care provider conversations about prenatal genetic screening: recommendation or personal choice. Obstet Gynecol. 2016;127:1145–52.CrossRef Colicchia LC, Holland CL, Tarr JA, Rubio DM, Rothenberger SD, Chang JC. Patient–health care provider conversations about prenatal genetic screening: recommendation or personal choice. Obstet Gynecol. 2016;127:1145–52.CrossRef
37.
go back to reference Zayts O, Schnurr S. More than ‘information provider’and ‘counselor’: constructing and negotiating roles and identities of nurses in genetic counseling sessions. J Sociolinguistics. 2014;18:345–69.CrossRef Zayts O, Schnurr S. More than ‘information provider’and ‘counselor’: constructing and negotiating roles and identities of nurses in genetic counseling sessions. J Sociolinguistics. 2014;18:345–69.CrossRef
38.
go back to reference Hertig SG, Cavalli S, Burton-Jeangros C, Elger BS. ‘Doctor, what would you do in my position?’ Health professionals and the decision-making process in pregnancy monitoring. J Med Ethics. 2014;40:310–4.CrossRef Hertig SG, Cavalli S, Burton-Jeangros C, Elger BS. ‘Doctor, what would you do in my position?’ Health professionals and the decision-making process in pregnancy monitoring. J Med Ethics. 2014;40:310–4.CrossRef
39.
go back to reference Filoche S, Cram F, Lawton B, Beard A, Stone P. Implementing non-invasive prenatal testing into publicly funded antenatal screening services for Down syndrome and other conditions in Aotearoa New Zealand. BMC Pregnancy Childbirth. 2017;17:344.CrossRef Filoche S, Cram F, Lawton B, Beard A, Stone P. Implementing non-invasive prenatal testing into publicly funded antenatal screening services for Down syndrome and other conditions in Aotearoa New Zealand. BMC Pregnancy Childbirth. 2017;17:344.CrossRef
40.
go back to reference Vanstone M, Cernat A, Nisker J, Schwartz L. Women’s perspectives on the ethical implications of non-invasive prenatal testing: a qualitative analysis to inform health policy decisions. BMC Med Ethics. 2018;19:27.CrossRef Vanstone M, Cernat A, Nisker J, Schwartz L. Women’s perspectives on the ethical implications of non-invasive prenatal testing: a qualitative analysis to inform health policy decisions. BMC Med Ethics. 2018;19:27.CrossRef
42.
go back to reference van Schendel RV, van El CG, Pajkrt E, Henneman L, Cornel MC. Implementing non-invasive prenatal testing for aneuploidy in a national healthcare system: global challenges and national solutions. BMC Health Serv Res. 2017;17:670.CrossRef van Schendel RV, van El CG, Pajkrt E, Henneman L, Cornel MC. Implementing non-invasive prenatal testing for aneuploidy in a national healthcare system: global challenges and national solutions. BMC Health Serv Res. 2017;17:670.CrossRef
43.
go back to reference Hayden EC. Prenatal-screening companies expand scope of DNA tests. Nature. 2014;507:19.CrossRef Hayden EC. Prenatal-screening companies expand scope of DNA tests. Nature. 2014;507:19.CrossRef
44.
go back to reference Farrell RM, Agatisa PK, Mercer MB, Mitchum AG, Coleridge MB. The use of noninvasive prenatal testing in obstetric care: educational resources, practice patterns, and barriers reported by a national sample of clinicians. Prenat Diagn. 2016;36:499–506.CrossRef Farrell RM, Agatisa PK, Mercer MB, Mitchum AG, Coleridge MB. The use of noninvasive prenatal testing in obstetric care: educational resources, practice patterns, and barriers reported by a national sample of clinicians. Prenat Diagn. 2016;36:499–506.CrossRef
45.
go back to reference Sahota DS. Noninvasive testing for fetal aneuploidy: a Hong Kong perspective. AJOB Empir Bioeth. 2015;6:106–10.CrossRef Sahota DS. Noninvasive testing for fetal aneuploidy: a Hong Kong perspective. AJOB Empir Bioeth. 2015;6:106–10.CrossRef
Metadata
Title
Service provision of non-invasive prenatal testing for Down syndrome in public and private healthcare sectors: a qualitative study with obstetric providers
Authors
Olivia Miu Yung Ngan
Huso Yi
Shenaz Ahmed
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2018
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-018-3540-9

Other articles of this Issue 1/2018

BMC Health Services Research 1/2018 Go to the issue